{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:49Z","timestamp":1741238689622,"version":"3.38.0"},"reference-count":65,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.nephro.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:04:29Z","timestamp":1669208669000},"page":"658-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prise en charge de la carence martiale au cours de la maladie r\u00e9nale chronique\u00a0: mise au point et proposition d\u2019un algorithme"],"prefix":"10.1684","volume":"18","author":[{"given":"Corinne","family":"Guibergia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2022.10.003_bib0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41581-019-0197-5","article-title":"The multifaceted role of iron in renal health and disease","volume":"16","author":"van Swelm","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0335","article-title":"M\u00e9tabolisme du fer: physiologie et pathologie","author":"Beaumont","year":"2015","journal-title":"EMC - H\u00e9matologie"},{"key":"10.1016\/j.nephro.2022.10.003_bib0340","article-title":"M\u00e9tabolisme du fer","author":"Brissot","year":"2015","journal-title":"EMC - Endocrinologie-Nutrition"},{"key":"10.1016\/j.nephro.2022.10.003_bib0345","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0350","first-page":"575","article-title":"\u00c9valuation de la mesure transcutan\u00e9e de la bilirubine et concordance avec la mesure sur sang total et plasma","volume":"64","author":"Carceller","year":"2006","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.nephro.2022.10.003_bib0355","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10\u00a0years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2022.10.003_bib0360","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-008-9086-x","article-title":"Iron and anemia in human biology: a review of mechanisms","volume":"13","author":"Handelman","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nephro.2022.10.003_bib0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3324\/haematol.11705","article-title":"Hepcidin: from discovery to differential diagnosis","volume":"93","author":"Kemna","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.nephro.2022.10.003_bib0370","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0375","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2022.10.003_bib0380","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","article-title":"The use of recombinant activated FVII in postpartum hemorrhage","volume":"53","author":"Franchini","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nephro.2022.10.003_bib0390","first-page":"155","article-title":"Anomalies et erreurs de d\u00e9termination de l\u2019h\u00e9mogramme avec les automates d\u2019h\u00e9matologie cellulaire Partie\u00a03. H\u00e9moglobine, h\u00e9maties, indices \u00e9rythrocytaires, r\u00e9ticulocytes","volume":"70","author":"Godon","year":"2012","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.nephro.2022.10.003_bib0395","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nephro.2022.10.003_bib0400","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"89","author":"MacDougall","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.10.003_bib0405","unstructured":"Organisation mondiale de la Sant\u00e9. Carences en micronutriments. https:\/\/apps.who.int\/nutrition\/topics\/ida\/fr\/index.html."},{"key":"10.1016\/j.nephro.2022.10.003_bib0410","unstructured":"Nutritional anaemias: tools for effective prevention and control. Geneva, Switzerland: World Health Organization; 2017."},{"key":"10.1016\/j.nephro.2022.10.003_bib0415","unstructured":"Assessing the iron status of populations: including literature reviews: report of a Joint World Health Organization\/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level. 2nd ed. ed. Geneva, Switerland: World Health Organization; 2004."},{"key":"10.1016\/j.nephro.2022.10.003_bib0420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0425","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ckj\/sfz091","article-title":"Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the chronic kidney disease outcomes and practice patterns study: often unmeasured, variably treated","volume":"13","author":"Wong","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2022.10.003_bib0430","doi-asserted-by":"crossref","first-page":"6S17","DOI":"10.1016\/S1769-7255(18)30647-3","article-title":"Complications m\u00e9taboliques en insuffisance r\u00e9nale chronique: hyperphosphat\u00e9mie, hyperkali\u00e9mie et an\u00e9mie","volume":"14","author":"Hannedouche","year":"2018","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2022.10.003_bib0435","unstructured":"\u00c9tude nationale nutrition sant\u00e9 (ENNS) 2006. Situation nutritionnelle en France en 2006\u00a0selon les indicateurs d\u2019objectif et les rep\u00e8res du Programme national nutrition sant\u00e9 (PNNS). 2007."},{"key":"10.1016\/j.nephro.2022.10.003_bib0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.nephro.2021.12.003","article-title":"Pr\u00e9valence de la carence martiale dans une population de patients insuffisants r\u00e9naux chroniques non dialys\u00e9s: \u00e9tude nationale multicentrique observationnelle CARENFER","author":"Choukroun","year":"2022","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2022.10.003_bib0445","article-title":"Troubles de l\u2019h\u00e9mostase au cours de l\u2019insuffisance r\u00e9nale chronique","author":"Brunet","year":"2007","journal-title":"EMC - N\u00e9phrologie"},{"key":"10.1016\/j.nephro.2022.10.003_bib0450","first-page":"2329","article-title":"Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia","volume":"91","author":"Chalasani","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0455","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-2004-835678","article-title":"Platelet dysfunction in renal failure","volume":"30","author":"Boccardo","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.nephro.2022.10.003_bib0460","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1742-7843.2010.00643.x","article-title":"Reduced platelet function and role of drugs in acute gastrointestinal bleeding","volume":"108","author":"Kringen","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0465","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.revmed.2018.03.007","article-title":"La carence martiale: nouvelles approches physiopathologiques et implications th\u00e9rapeutiques","volume":"39","author":"Cacoub","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.nephro.2022.10.003_bib0470","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/10408363.2019.1653820","article-title":"Using transferrin saturation as a diagnostic criterion for iron deficiency: a systematic review","volume":"56","author":"Cacoub","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.nephro.2022.10.003_bib0475","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/hdi.12542","article-title":"Overview of iron metabolism in health and disease","author":"Dev","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nephro.2022.10.003_bib0480","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2022.10.003_bib0485","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nephro.2022.10.003_bib0490","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0495","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nephro.2022.10.003_bib0500","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nephro.2022.10.003_bib0505","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021\u00a0ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nephro.2022.10.003_bib0510","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.ekir.2021.07.032","article-title":"Iron deficiency in CKD without concomitant anemia","volume":"6","author":"Wish","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.nephro.2022.10.003_bib0515","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","article-title":"Iron deficiency","volume":"397","author":"Pasricha","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2022.10.003_bib0520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000496492","article-title":"Iron deficiency anemia in chronic kidney disease","volume":"142","author":"Gafter-Gvili","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0525","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.03980808","article-title":"Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease","volume":"4","author":"Kovesdy","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0530","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12882-018-1021-3","article-title":"Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease","volume":"19","author":"Eisenga","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0535","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.kint.2019.04.029","article-title":"An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease","volume":"96","author":"Cho","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.10.003_bib0540","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1681\/ASN.2020101531","article-title":"Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia","volume":"32","author":"Guedes","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0545","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2215\/CJN.15360920","article-title":"Heart failure hospitalization risk associated with iron status in veterans with CKD","volume":"16","author":"Cho","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0550","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a european renal best practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.10.003_bib0555","first-page":"279","article-title":"Clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"Co-Chairs KDIGO","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nephro.2022.10.003_bib0560","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/ckj\/sfx070","article-title":"Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients","volume":"10","author":"Malyszko","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2022.10.003_bib0565","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nephro.2022.10.003_bib0570","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.10.003_bib0575","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5414\/CN109198","article-title":"Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial","volume":"88","author":"Macdougall","year":"2017","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0580","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nephro.2018.10.006","volume":"15","author":"Romanet","year":"2019","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2022.10.003_bib0585","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"MacDougall","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2022.10.003_bib0590","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.nephro.2013.07.364","article-title":"La prise en charge de l\u2019an\u00e9mie et de ses cons\u00e9quences chez les patients d\u00e9butant l\u2019h\u00e9modialyse: importance du fer intraveineux en pr\u00e9dialyse","volume":"9","author":"Rottembourg","year":"2013","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2022.10.003_bib0595","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.xkme.2020.01.006","article-title":"Iron administration, infection, and anemia management in CKD: untangling the effects of intravenous iron therapy on immunity and infection risk","volume":"2","author":"Ganz","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.nephro.2022.10.003_bib0600","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000486968","article-title":"Positive iron balance in chronic kidney disease: how much is too much and how to tell?","volume":"47","author":"Wish","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0605","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nephro.2015.04.009","article-title":"Utilisation des d\u00e9riv\u00e9s injectables du fer au cours de la maladie r\u00e9nale chronique: int\u00e9r\u00eats, limites et conseils pour un bon usage","volume":"11","author":"Rottembourg","year":"2015","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2022.10.003_bib0610","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/ndt\/gfw264","article-title":"Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial","volume":"32","author":"Roger","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2022.10.003_bib0615","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2215\/CJN.05390517","article-title":"Safety of intravenous iron in dialysis: a systematic review and meta-analysis","volume":"13","author":"Hougen","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2022.10.003_bib0620","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/joim.13503","article-title":"Iron deficiency screening is a key issue in chronic inflammatory diseases: a call to action","volume":"292","author":"Cacoub","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.nephro.2022.10.003_bib0625","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.10.003_bib0630","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ki.2015.302","article-title":"New data on the safety of IV iron\u2013but why the discrepancy with FIND-CKD?","volume":"88","author":"Macdougall","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2022.10.003_bib0635","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nephro.2022.10.003_bib0640","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2022.10.003_bib0645","first-page":"3","article-title":"Randomized trial of intravenous iron-induced hypophosphatemia","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.nephro.2022.10.003_bib0325","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jbmr.3369","article-title":"Iron supplementation-induced phosphaturic osteomalacia: FGF23\u00a0is the culprit","volume":"33","author":"Urbina","year":"2018","journal-title":"J Bone Miner Res"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522006174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725522006174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2022.10.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:23:41Z","timestamp":1741191821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725522006174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1769725522006174"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2022.10.003","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge de la carence martiale au cours de la maladie r\u00e9nale chronique\u00a0: mise au point et proposition d\u2019un algorithme","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}